Hepatocellular carcinoma (HCC) is an invasive malignant tumour and the second major cause of cancer-related deaths over the world. CRNDE and miR-217 are noncoding RNAs which play critical roles in cell growth, proliferation, migration. Mitogen-activated protein kinase 1 (MAPK1) also participates in cancer cell process.
| INTRODUCTION
As the predominant liver malignancy, hepatocellular carcinoma (HCC) is the second major cause of cancer death in the world. 1 In spite of remarkable efforts to discover novel therapeutic strategies against HCC, the long-term survival rate remains dismal. Cancer metastasis and poor prognosis are two major obstacles in HCC therapy. 2 Most of HCC patients still suffer from metastasis and recurrence after treatment. The molecular mechanism underlying HCC has not been clearly characterized. Thus, it is extremely critical to promote researches on molecular biomarkers which regulate metastatic behaviour and prognosis evaluation of HCC. 3 Recently, an increasing number of studies have revealed the crucial role of non-coding RNAs in HCC, including long non-coding RNA (lncRNAs) and microRNAs (miRNAs). 4, 5 LncRNAs are a class of poor conserved endogenous RNAs longer than 200 nucleotides that do not encode proteins but regulate gene expression. 6 In recent years, accumulating evidences have revealed the importance of lncRNAs on cancer metastasis and development, suggesting the involvement of lncRNAs in cancer progression. 7, 8 The lncRNA Colorectal Neoplasia Differentially Expressed (CRNDE), which was initially found to increase in colorectal cancer, was also overexpressed in various malignant diseases including HCC. 9 Current evidences have suggested that CRNDE exert influence on the propagation and metastasis of malignant carcinoma. 10 However, the expression profiles and precise biological functions of CRNDE in HCC remain largely unknown.
On the other hand, miRNAs, a class of endogenous non-coding RNAs with 20-25 nucleotides length, have been proved to modulate mRNA stability and protein translation. 11 MiRNAs play a crucial role in cancer development process such as differentiation, proliferation and metastasis. 12 According to previous studies, microRNA 217 (miR-217) was linked with cell progression as a tumour suppressor. 13, 14 But, the mechanism of miR-217 is still not clear in
HCC.
Epithelial-to-mesenchymal transition (EMT), the process by which epithelial cells gain migratory and invasive properties, has been identified as an important process in cancer progression, especially in HCC. 15 Dysregulated expression of lncRNAs and miRNAs were reported to mediate the EMT progression in HCC cells. 16, 17 Consequently, lncRNAs and miRNAs are considered as potential novel therapeutic targets against the poor prognosis and metastasis of HCC. Meanwhile, mitogen-activated protein kinase 1 (MAPK1) is involved in a variety of cancer cell processes such as proliferation and migration. 18 MAPK1 has been proved to mediate EMT as an intracellular signalling molecule, and some signalling molecules can also affect EMT progression through MAPK1 pathway. 19 Zhang et al found that miR-217 regulated tumour growth and apoptosis by targeting the MAPK signalling pathway in colorectal cancer. 20 Nevertheless, there are only a few reports about the interaction among CRNDE, miR-217 and MAPK1 in HCC cells.
Recently, some studies revealed that one potential function of lncRNAs was to directly interact with miRNAs, regulating their expression and activity. 21 In recently described mechanism, lncRNAs might function as competitive endogenous RNAs to sponge specific miRNAs, thereby mediating the de-repression of miRNAs targets. 22 For instance, lncRNA MALAT1 facilitated migration and invasiveness by modulating miR-1 in breast cancer. 23 LncRNA H19 regulated cancer cell propagation by regulating miR-194-5p. 24 LncRNA UCA1 exerted oncogenic effects by targeting mir-193a-3p in lung cancer. 25 We therefore hypothesized that CRNDE might also directly interact with some particular miRNAs. 
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| RESULTS

| CRNDE was screened out by microarray analysis
Ten pairs of HCC tissues and adjacent tissues were used to perform microarray. Fold change > 2 and P < 0.05 were applied to explore the abnormal lncRNA expressions. The volcanic plot and the heat map of lncRNA expression reflected that compared with adjacent normal tissues, CRNDE was up-regulated in HCC tumour tissues.
( Figure 1A and B). Figure 4C , overexpressed CRNDE observably decreased E-cadherin/Mucin-1 protein levels and increased Vimentin/Fibronectin protein levels (P < 0.01), whereas the miR-217 affected on the contrary (P < 0.01). Sh-CRNDE conspicuously increased E-cadherin/Mucin-1 protein levels and decreased Vimentin/ Fibronectin protein levels (P < 0.01), whereas the anti-miR-217 had an opposite effect (P < 0.01). Therefore, CRNDE enhance proliferation, migration and invasion by promoting EMT process via regulating miR-217 in HCC cells was evidenced preliminarily.
| MAPK1 was the target of miR-217 and was regulated by CRNDE/miR-217 axis
Bioinformatics analysis was utilized to predict that MAPK1 was the MiR-217 conspicuously increased E-cadherin/Mucin-1 protein levels and decreased Vimentin/Fibronectin protein levels, whereas the MAPK1 generated an opposite effect ( Figure 7C , P < 0.01). To sum up, miR-217/MAPK1 regulatory axis played a role in regulating HCC progress.
| CRNDE/miR-217 were related with the expression of EMT markers and participated in mediating MAPK1 signalling
Pearson correlative analysis suggested the expression of EMT marker E-cadherin was negatively correlated with CRNDE expression but F I G U R E 4 CRNDE/miR-217 took part in cell migration, invasion and EMT regulatory process. (A) Transwell assay showed that CRNDE and down-regulated miR-217 could enhance cell migration and invasion abilities, down-regulated CRNDE and miR-217 could weaken capacities of cell migration and invasion. (B) Wound healing assay was performed for further verification of cell migration abilities. (C) Western blot exhibited the protein expression levels of epithelial makers E-cadherin/Mucin-1 were reduced by CRNDE and anti-miR-217. Besides, the results were conversed by miR-217 and sh-CRNDE. Furthermore, the protein expression levels of mesenchymal markers Vimentin/Fibronectin were increased following the EMT activation. **P < 0.01, compared with NC group. 
| DISCUSSION
HCC has been regarded as a common malignant tumour for high recurrence and poor prognosis. 2 Targeting the metastasis of HCC cells has become a therapeutic object for developing novel HCC treatments. So far, mounting evidences have indicated that lncRNAs had close connection with the HCC progression. 26 For instance, Lan et al have reported that HCC tumorigenesis was accelerated by lncRNA PVT1. 27 In addition, Lu et al proved that overexpressed lncRNA HOXD-AS1 was a critical regulator of metastasis in HCC. 28 CRNDE has been identified to promote tumour development, 9, 29 and its function in HCC remains had been preliminarily revealed in some research, such as Chen et al revealed that CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. 30 In this study, CRNDE expression was proved to be remarkably increased in HCC and the results are consistent with previous studies. Up till now, a number of lncRNAs have been characterized as regulators in HCC cells metastasis process. 31 In in vitro experiments, we found that CRNDE facilitated HCC cells metastasis and promoted the EMT progression by decreasing E-cadherin/Mucin- 38 Huan et al revealed that lncRNA CRNDE activated Wnt/β-catenin pathway through acting as sponge of miR-136 in breast cancer. 39 We did experiments to further explore the underlying mechanisms involved in CRNDE, miR-217
and MAPK1, and we found that CRNDE could positively regulate the c-Myc encodes a transcription factor that can drive proliferation by promoting downstream cell cycle pathway. 40 Furthermore, Shi et al proved c-Myc was the major transcription factor promoting VEGF expression, 41 Fantozzi et al discovered VEGF signalling-mediated angiogenesis links EMT-induced cancer stemness to tumour initiation. 42 VEGF promoted tension-independent FAK signalling activation Relative CRNDE expression Relative Vimentin expression F I G U R E 8 CRNDE/miR-217 were related to EMT process and MAPK1 signalling pathway. (A) Expression of EMT markers was related with CRNDE/miR-217 expression. (B, C) The protein expression levels of MAPK1 and down-stream c-Myc were regulated by CRNDE/miR-217 axis. **P < 0.01, compared with NC group. ## P < 0.01, compared with anti-miR-217+sh-MAPK1/miR-217+MAPK1 group the pathogenesis of HCC, some deficiencies in our study should be ameliorated in future researches. For example, in vivo experiment should be employed to verify the molecular mechanism of CRNDE/ miR-217/MAPK1 axis.
In conclusion, this study elucidated that CRNDE was increased in HCC and promoted migration, invasiveness and EMT progression of HCC cells via CRNDE/miR-217/MAPK1 axis. Specifically, CRNDE could promote HCC process as a molecular sponge of miR-217, which targeting MAPK1 pathway. We preliminarily clarified the relationship between CRNDE and miR-217. Promising therapeutic strategies against HCC might be established by targeting CENDE or repairing the balance between miR-217 and MAPK1.
